A Phase 1 Clinical Trial of High Dose AAV1.SERCA2a in Patients with Heart Failure: Modulation of SERCA2a of Intramyocytic Calcium trafficking in Heart Failure with Reduced Ejection Fraction (MUSIC-HFrEF)

被引：0
|
作者：
Jaski, Brian [1 ]
Cheng, Richard [2 ]
Rudy, Jeffrey [3 ]
Li, Ronald A. [4 ]
Hajjar, Roger [3 ]
机构：
[1] San Diego Cardiac Ctr, San Diego, CA USA
[2] Univ Calif San Francisco, San Francisco, CA USA
[3] Sardocor Corp, Boston, MA USA
[4] Medera Inc, Boston, MA USA
来源：
MOLECULAR THERAPY | 2024年 / 32卷 / 05期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
5
引用
收藏
页码：3 / 3
页数：1
相关论文
共 50 条
  • [1] Design of a phase 1/2 trial of intracoronary administration of AAV1/SERCA2a in patients with heart failure
    Hajjar, Roger J.
    Zsebo, Krisztina
    Deckelbaum, Lawrence
    Thompson, Craig
    Rudy, Jeff
    Yaroshinsky, Alex
    Ly, Hung
    Kawase, Yoshiaki
    Wagner, Kim
    Borow, Kenneth
    Jaski, Brian
    London, Barry
    Greenberg, Barry
    Pauly, Daniel F.
    Patten, Richard
    Starling, Randall
    Mancini, Donna
    Jessup, Mariell
    JOURNAL OF CARDIAC FAILURE, 2008, 14 (05) : 355 - 367
  • [2] SUMO1-dependent modulation of SERCA2a in heart failure
    Kho, Changwon
    Lee, Ahyoung
    Jeong, Dongtak
    Oh, Jae Gyun
    Chaanine, Antoine H.
    Kizana, Eddy
    Park, Woo Jin
    Hajjar, Roger J.
    NATURE, 2011, 477 (7366) : 601 - U263
  • [3] SUMO1-dependent modulation of SERCA2a in heart failure
    Changwon Kho
    Ahyoung Lee
    Dongtak Jeong
    Jae Gyun Oh
    Antoine H. Chaanine
    Eddy Kizana
    Woo Jin Park
    Roger J. Hajjar
    Nature, 2011, 477 : 601 - 605
  • [4] SERCA2a microdomain cAMP changes in heart failure with preserved ejection fraction
    Gotthardt, Michael
    Lehnart, Stephan E.
    CARDIOVASCULAR RESEARCH, 2024, 120 (03) : 220 - 222
  • [5] Hemodynamic Response to Exercise in Heart Failure With Preserved Ejection Fraction (HFpEF) Patients After Upregulation of SERCA2a
    Sarma, Satyam
    Hieda, Michinari
    Howden, Erin J.
    Hearon, Christopher
    Lawley, Justin
    Livingston, Sheryl
    Samels, Mitchel
    Everding, Braden
    Levine, Benjamin D.
    CIRCULATION, 2017, 136
  • [6] SERCA2a dysfunction in the pathophysiology of heart failure with preserved ejection fraction: a direct role is yet to be established
    Shooshtarian, Adam Kia
    O'Gallagher, Kevin
    Shah, Ajay M.
    Zhang, Min
    HEART FAILURE REVIEWS, 2025, : 545 - 564
  • [7] SERCA2a Agonist Effects on Cardiac Performance During Exercise in Heart Failure With Preserved Ejection Fraction
    Sarma, Satyam
    Macnamara, James P.
    Hieda, Michinari
    Howden, Erin J.
    Lawley, Justin S.
    Livingston, Sheryl
    Samels, Mitchel
    Levine, Benjamin D.
    JACC-HEART FAILURE, 2023, 11 (07) : 760 - 771
  • [8] CUPID 2: A Phase 2b Trial Investigating the Efficacy and Safety of the Intracoronary Administration of AAV1/SERCA2a in Patients with Advanced Heart Failure
    Greenberg, Barry
    Butler, Javed
    Felker, G. Michael
    Ponikowski, Piotr
    Voors, Adriaan A.
    Jaski, Brian
    Lyon, Alexander R.
    Pogoda, Janice M.
    Rudy, Jeffrey J.
    Zsebo, Krisztina M.
    JOURNAL OF CARDIAC FAILURE, 2015, 21 (11) : 939 - 940
  • [9] SUMO1 Modification Regulates SR Calcium ATPase Pump, SERCA2a in Heart Failure
    Kho, Changwon
    Lee, Ahyoung
    Jeong, Dongtak
    Oh, Jae Gyun
    Chaanine, Antoine
    Park, Woo Jin
    Hajjar, Roger
    CIRCULATION RESEARCH, 2012, 111 (04)
  • [10] Investigation of the safety and feasibility of AAV1/SERCA2a gene transfer in patients with chronic heart failure supported with a left ventricular assist device – the SERCA-LVAD TRIAL
    A. R. Lyon
    D. Babalis
    A. C. Morley-Smith
    M. Hedger
    A. Suarez Barrientos
    G. Foldes
    L. S. Couch
    R. A. Chowdhury
    K. N. Tzortzis
    N. S. Peters
    E. A. Rog-Zielinska
    H-Y Yang
    S. Welch
    C. T. Bowles
    S. Rahman Haley
    A. R. Bell
    A. Rice
    T. Sasikaran
    N. A. Johnson
    E. Falaschetti
    J. Parameshwar
    C. Lewis
    S. Tsui
    A. Simon
    J. Pepper
    J. J. Rudy
    K. M. Zsebo
    K. T. Macleod
    C. M. Terracciano
    R. J. Hajjar
    N. Banner
    S. E. Harding
    Gene Therapy, 2020, 27 : 579 - 590
12345